James M. Ahlers - 29 Jun 2023 Form 3 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
Executive VP of CF
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Issuer symbol
INTS
Transactions as of
29 Jun 2023
Net transactions value
$0
Form type
3
Filing time
29 Jun 2023, 19:54:37 UTC
Previous filing
20 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INTS Warrants (Right to buy Common Stock) 29 Jun 2023 Common Stock 5,000 $9.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Warrants will vest with regard to shares of Common Stock, subject to the individual's continued service with Intensity Therapeutics Inc., in four equal installments, beginning on December 13, 2023.

Remarks:

Exhibit 24 - Power of Attorney